Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $111.57 billion. The enterprise value is $131.37 billion.
| Market Cap | 111.57B |
| Enterprise Value | 131.37B |
Important Dates
The next confirmed earnings date is Tuesday, September 1, 2026, before market open.
| Earnings Date | Sep 1, 2026 |
| Ex-Dividend Date | Jun 26, 2026 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -0.14% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 86.85% |
| Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 23.37 and the forward PE ratio is 14.65. Medtronic's PEG ratio is 2.77.
| PE Ratio | 23.37 |
| Forward PE | 14.65 |
| PS Ratio | 3.07 |
| Forward PS | 2.87 |
| PB Ratio | 2.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.56 |
| P/OCF Ratio | 15.22 |
| PEG Ratio | 2.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.94, with an EV/FCF ratio of 24.21.
| EV / Earnings | 27.36 |
| EV / Sales | 3.61 |
| EV / EBITDA | 13.94 |
| EV / EBIT | 20.31 |
| EV / FCF | 24.21 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.58.
| Current Ratio | 2.13 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 3.09 |
| Debt / FCF | 5.37 |
| Interest Coverage | 9.04 |
Financial Efficiency
Return on equity (ROE) is 9.84% and return on invested capital (ROIC) is 8.25%.
| Return on Equity (ROE) | 9.84% |
| Return on Assets (ROA) | 4.92% |
| Return on Invested Capital (ROIC) | 8.25% |
| Return on Capital Employed (ROCE) | 7.95% |
| Weighted Average Cost of Capital (WACC) | 6.24% |
| Revenue Per Employee | $382,779 |
| Profits Per Employee | $50,537 |
| Employee Count | 95,000 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.21 |
Taxes
In the past 12 months, Medtronic has paid $1.30 billion in taxes.
| Income Tax | 1.30B |
| Effective Tax Rate | 21.17% |
Stock Price Statistics
The stock price has decreased by -2.46% in the last 52 weeks. The beta is 0.57, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -2.46% |
| 50-Day Moving Average | 81.68 |
| 200-Day Moving Average | 89.88 |
| Relative Strength Index (RSI) | 61.92 |
| Average Volume (20 Days) | 6,767,655 |
Short Selling Information
The latest short interest is 19.03 million, so 1.49% of the outstanding shares have been sold short.
| Short Interest | 19.03M |
| Short Previous Month | 18.43M |
| Short % of Shares Out | 1.49% |
| Short % of Float | 1.51% |
| Short Ratio (days to cover) | 2.05 |
Income Statement
In the last 12 months, Medtronic had revenue of $36.36 billion and earned $4.80 billion in profits. Earnings per share was $3.73.
| Revenue | 36.36B |
| Gross Profit | 23.75B |
| Operating Income | 7.27B |
| Pretax Income | 6.14B |
| Net Income | 4.80B |
| EBITDA | 9.43B |
| EBIT | 6.47B |
| Earnings Per Share (EPS) | $3.73 |
Balance Sheet
The company has $9.22 billion in cash and $29.15 billion in debt, with a net cash position of -$19.80 billion or -$15.47 per share.
| Cash & Cash Equivalents | 9.22B |
| Total Debt | 29.15B |
| Net Cash | -19.80B |
| Net Cash Per Share | -$15.47 |
| Equity (Book Value) | 50.07B |
| Book Value Per Share | 38.64 |
| Working Capital | 13.13B |
Cash Flow
In the last 12 months, operating cash flow was $7.33 billion and capital expenditures -$1.90 billion, giving a free cash flow of $5.43 billion.
| Operating Cash Flow | 7.33B |
| Capital Expenditures | -1.90B |
| Depreciation & Amortization | 2.84B |
| Net Borrowing | -1.17B |
| Free Cash Flow | 5.43B |
| FCF Per Share | $4.24 |
Margins
Gross margin is 65.31%, with operating and profit margins of 19.98% and 13.20%.
| Gross Margin | 65.31% |
| Operating Margin | 19.98% |
| Pretax Margin | 16.88% |
| Profit Margin | 13.20% |
| EBITDA Margin | 25.92% |
| EBIT Margin | 17.78% |
| FCF Margin | 14.92% |
Dividends & Yields
This stock pays an annual dividend of $2.88, which amounts to a dividend yield of 3.30%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 3.30% |
| Dividend Growth (YoY) | 1.42% |
| Years of Dividend Growth | 50 |
| Payout Ratio | 77.21% |
| Buyback Yield | 0.14% |
| Shareholder Yield | 3.44% |
| Earnings Yield | 4.30% |
| FCF Yield | 4.86% |
Analyst Forecast
The average price target for Medtronic is $98.44, which is 12.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $98.44 |
| Price Target Difference | 12.94% |
| Analyst Consensus | Buy |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 5.04% |
| EPS Growth Forecast (3Y) | 7.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.97 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.97 |
| Piotroski F-Score | 6 |